Transatlantic Alliance Series: Polycystic Ovary Syndrome
(4)
Image For Activity Cover
Availability
On-Demand
Expires on 12/31/2025
Cost
$0.00
Credit Offered
1.5 AMA PRA Category 1 Credits
1.5 Participation Credits
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended

The Transatlantic Alliance Webinar Series is dedicated to highlighting the ongoing collaborations between the Endocrine Society and the European Society of Endocrinology on key issues in endocrinology.

In our inaugural webinar, subject matter experts will review the recent guideline on polycystic ovary syndrome, developed in partnership with over 30 professional societies and advocacy groups.

The "2023 International evidence-based guideline on the assessment and management of polycystic ovary syndrome" is designed to provide clear information to assist shared decision-making and support optimal patient care and better health outcomes for the one in eight women affected by this condition.

Looking for the guideline and related resources? Access them here on Monash University's website

This presentation is targeted to all healthcare professionals who oversee the diagnosis and management of polycystic ovary syndrome.

Following participation in this activity, learners should be able to better understand the:

  1. Updated International Guideline Diagnostic Criteria  for PCOS
  2. Broad psychological, cardiometabolic, reproductive and dermatological features of PCOS
  3. Screening and prevention strategies
  4. Effective treatments, and
  5. Available resources for patients and health professionals 

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit

The Endocrine Society designates each activity in this course for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

European Accreditation Council for Continuing Medical Education
The European Accreditation Council for Continuing Medical Education (EACCME) and the American Medical Association (AMA) signed an agreement of mutual recognition of CME credits between Europe and the USA whereby: European physicians attending an event in the USA had their credits recognized in Europe and American physicians attending an event in Europe had their credits recognized in the USA.

The Endocrine Society designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Each medical specialist should claim only those credits that he/she actually spent in the educational activity. These credits can be converted by the EACCME into European CME credits and/or into National credits by the European National Authorities.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)

Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1.50 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Anuja Dokras, MD, PhD
Penn Medicine
University of Pennsylvania
Philadelphia, PA

Rachel Mormon
Patient Representative
Verity
United Kingdom

Helena Teede, AM, PhD, MBBS, FRACP, FAAHMS, FRANZCOG, FRCOG 
Monash Partners Academic Health Science Centre 
Monash University
Melbourne, Australia

Bulent Yildiz, MD
Hacettepe University School of Medicine 
Ankara, Turkey

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

  • Anuja Dokras, MD, PhD; Rachel Mormon; Bulent Yildiz, MD; Helena Teede, AM, PhD, MBBS, FRACP, FAAHMS, FRANZCOG, FRCOG 

Note: the content presented in this activity is exclusively from "International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS)", a peer-reviewed clinical practice guideline developed by a large group of subject matter experts from relevant professional societies and advocacy groups. The full list of disclosures for all participating experts can be found here.

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By